Vincent has over 20 years of experience in bioprocess development and manufacturing, with deep expertise spanning recombinant proteins, monoclonal antibodies, vaccines and gene therapies. He has held senior leadership roles in biotech and CDMO environments, where he managed cross-functional teams, led large-scale CMC programs from early discovery to late-stage clinical supply, and supported global regulatory filings.

Prior experience:

• CMC Director, Vivet Therapeutics (2021–2025)
• Associate Director, Biotech Process Sciences, Merck Group (2017–2021)
• Strategic Project Director & R&D Director, Novasep Biopharma Business Unit (2010–2019)
• Director of Development & Production, PX’Therapeutics (2009–2010)
• Director of Technological Development, PX’Therapeutics (2003–2008)
• Project Development Manager, PX’Therapeutics (2002–2003)
• Project Manager, CNRS-AVENTIS (2000–2002)
• Research Associate, Newcastle University (1998–1999)

Education:

• PhD in Molecular and Cellular Biology & Genetics, INSA Toulouse
• Master’s Degree, INSA Toulouse